Antonella Conforti

5PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Microfluidics and nanofluidicsAgricultural molecular engineering of nucleic acids and proteinsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 04, 2025
From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy.

E Pinto, L Lione, M Compagnone

|Mar 30, 2023
Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms.

Federico D'Alessio, Lucia Lione, Erika Salvatori

|Jul 27, 2022
DNA-Vaccine-Induced Immune Response Correlates with Lower Viral SARS-CoV-2 Titers in a Ferret Model.

Mirco Compagnone, Eleonora Pinto, Erika Salvatori

|Jun 06, 2022
Linear DNA amplicons as a novel cancer vaccine strategy.

Antonella Conforti, Erika Salvatori, Lucia Lione

|Feb 03, 2022
Neoantigen cancer vaccine augments anti-CTLA-4 efficacy.

Erika Salvatori, Lucia Lione, Mirco Compagnone

Pageof 1

Frequent Collaborators

3 joint publications

Erika Salvatori

3 joint publications

Lucia Lione

3 joint publications

Eleonora Pinto

3 joint publications

Luigi Aurisicchio